Data / Form D filings / SMSA GAINESVILLE ACQUISITION CORP.
SMSA GAINESVILLE ACQUISITION CORP.: Form D filings
SMSA GAINESVILLE ACQUISITION CORP., a pharmaceuticals company in Plano, TX, filed 2 Form D notices with the SEC in 2014. The latest, on April 15, 2014, reports $30,000 sold of a $5.4 million offering to 6 investors.
Find out what SMSA GAINESVILLE ACQUISITION CORP. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 610 COIT ROAD, SUITE 200, Plano, TX, 75075
- Phone
- (832) 494-3212
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1474266
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 15, 2014 | Amendment | $5,375,000 | $30,000 | $5,345,000 | 6 | Apr 3, 2014 | sec.gov |
| Mar 25, 2014 | New notice | $5,375,000 | $20,000 | $5,355,000 | 4 | Mar 10, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert E Ham | Executive Officer | |
| Maulik Parikh | Executive Officer | |
| Kamran Nezami | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Apr 14, 2014 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SMSA GAINESVILLE ACQUISITION CORP. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.